D'ONGHIA, MARIANGELA
D'ONGHIA, MARIANGELA
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis
2018-01-01 Tortorella, Carla; Direnzo, Vita; Ruggieri, Maddalena; Zoccolella, Stefano; Mastrapasqua, Mariangela; D'Onghia, Mariangela; Paolicelli, Damiano; Di Cuonzo, Franca; Gasperini, Claudio; Trojano, Maria
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study
2015-01-01 Paolicelli, Damiano; Manni, Alessia; Direnzo, Vita; D'Onghia, Mariangela; Tortorella, Carla; Zoccolella, Stefano; Troiano, Maria
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients
2016-01-01 Paolicelli, Damiano; Direnzo, Vita; Manni, Alessia; D'Onghia, Mariangela; Tortorella, Carla; Zoccolella, Stefano; Di Lecce, Valentina; Iaffaldano, Antonio; Troiano, Maria
Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort
2019-01-01 Manni, Alessia; Iaffaldano, A.; Lucisano, G.; D'Onghia, M.; Mezzapesa, D. M.; Felica, Vincenzo; Iaffaldano, P.; Trojano, M.; Paolicelli, D.
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients
2017-01-01 Paolicelli, Damiano; Manni, Alessia; D'Onghia, Mariangela; Direnzo, Vita; Iaffaldano, Pietro; Zoccolella, Stefano; DI LECCE, Valentina; Tortorella, C.; Specchia, Giorgina; Troiano, Maria
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta
2015-01-01 Paolicelli, Damiano; Iannazzo, S; Santoni, L; D'Onghia, Mariangela; Direnzo, Vita; Iaffaldano, A; Puma, E; Di Lecce, V; Troiano, Maria
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy
2016-01-01 Paolicelli, Damiano; Iannazzo, Sergio; Santoni, Laura; Iaffaldano, Antonio; Lecce, Valentina Di; Manni, Alessia; Lavolpe, Vito Grazio; Tortorella, Carla; D'Onghia, Mariangela; Direnzo, Vita; Puma, Elisa; Troiano, Maria
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study
2016-01-01 Paolicelli, Damiano; Manni, A.; Iaffaldano, A.; Di Lecce, V.; D'Onghia, Mariangela; Iaffaldano, Pietro; Troiano, Maria
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis | 1-gen-2018 | Tortorella, Carla; Direnzo, Vita; Ruggieri, Maddalena; Zoccolella, Stefano; Mastrapasqua, Mariangela; D'Onghia, Mariangela; Paolicelli, Damiano; Di Cuonzo, Franca; Gasperini, Claudio; Trojano, Maria | |
| Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study | 1-gen-2015 | Paolicelli, Damiano; Manni, Alessia; Direnzo, Vita; D'Onghia, Mariangela; Tortorella, Carla; Zoccolella, Stefano; Troiano, Maria | |
| Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients | 1-gen-2016 | Paolicelli, Damiano; Direnzo, Vita; Manni, Alessia; D'Onghia, Mariangela; Tortorella, Carla; Zoccolella, Stefano; Di Lecce, Valentina; Iaffaldano, Antonio; Troiano, Maria | |
| Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort | 1-gen-2019 | Manni, Alessia; Iaffaldano, A.; Lucisano, G.; D'Onghia, M.; Mezzapesa, D. M.; Felica, Vincenzo; Iaffaldano, P.; Trojano, M.; Paolicelli, D. | |
| Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients | 1-gen-2017 | Paolicelli, Damiano; Manni, Alessia; D'Onghia, Mariangela; Direnzo, Vita; Iaffaldano, Pietro; Zoccolella, Stefano; DI LECCE, Valentina; Tortorella, C.; Specchia, Giorgina; Troiano, Maria | |
| The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta | 1-gen-2015 | Paolicelli, Damiano; Iannazzo, S; Santoni, L; D'Onghia, Mariangela; Direnzo, Vita; Iaffaldano, A; Puma, E; Di Lecce, V; Troiano, Maria | |
| The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy | 1-gen-2016 | Paolicelli, Damiano; Iannazzo, Sergio; Santoni, Laura; Iaffaldano, Antonio; Lecce, Valentina Di; Manni, Alessia; Lavolpe, Vito Grazio; Tortorella, Carla; D'Onghia, Mariangela; Direnzo, Vita; Puma, Elisa; Troiano, Maria | |
| The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study | 1-gen-2016 | Paolicelli, Damiano; Manni, A.; Iaffaldano, A.; Di Lecce, V.; D'Onghia, Mariangela; Iaffaldano, Pietro; Troiano, Maria |